机构:[1]Department of Sports Medicine, Peking University Third Hospital, Institute of Sports Medicine of Peking University, Beijing Key Laboratory of Sports Injuries, Beijing 100191, China[2]Peking University First Hospital, Peking University Health Science Center, Beijing 100034, China[3]Engineering Research Center of Sports Trauma Treatment Technology and Devices, Ministry of Education, Beijing 100191, China[4]Institute of Cerebrovascular Diseases Research and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China神经科系统神经内科首都医科大学宣武医院
This research was funded by Innovation and Transformation Fund of
Peking University Third Hospital (grant number: BYSYZHKC2023114)
and Peking University Medicine Sailing Program for Young Scholars’
Scientific & Technological Innovation (grant number
BMU2023YFJHMX008).
第一作者机构:[1]Department of Sports Medicine, Peking University Third Hospital, Institute of Sports Medicine of Peking University, Beijing Key Laboratory of Sports Injuries, Beijing 100191, China[2]Peking University First Hospital, Peking University Health Science Center, Beijing 100034, China[3]Engineering Research Center of Sports Trauma Treatment Technology and Devices, Ministry of Education, Beijing 100191, China
共同第一作者:
通讯作者:
通讯机构:[1]Department of Sports Medicine, Peking University Third Hospital, Institute of Sports Medicine of Peking University, Beijing Key Laboratory of Sports Injuries, Beijing 100191, China[3]Engineering Research Center of Sports Trauma Treatment Technology and Devices, Ministry of Education, Beijing 100191, China
推荐引用方式(GB/T 7714):
Chen Huizhu,Han Ziping,Ma Yong,et al.Advances in macrophage-derived exosomes as immunomodulators in disease progression and therapy[J].International Immunopharmacology.2024,142:113248.doi:10.1016/j.intimp.2024.113248.
APA:
Chen Huizhu,Han Ziping,Ma Yong&Meng Qingyang.(2024).Advances in macrophage-derived exosomes as immunomodulators in disease progression and therapy.International Immunopharmacology,142,
MLA:
Chen Huizhu,et al."Advances in macrophage-derived exosomes as immunomodulators in disease progression and therapy".International Immunopharmacology 142.(2024):113248